Puget Sound Drug Corporation dba Key Pharmacy and Compoundin
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on April 04, 2018
Executive Summary
The FDA issued a warning letter to Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center on April 04, 2018 citing regulatory violations. The letter was issued by Los Angeles District Office.
Detailed Analysis
False Claims and Regulatory Violations
The FDA identified regulatory violations in Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center's operations or product claims.
Potential Health Risks
Consumers should be aware of potential risks associated with products from Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center.
Regulatory Context
This warning letter is part of the FDA's enforcement of federal regulations.
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center products?
- If you have used products from Puget Sound Drug Corporation dba Key Pharmacy and Compounding Center and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter